AutogenAI raises £31.4m in Series B funding co-led by Salesforce Ventures and Spark Capital to expand its bid-writing platform.
The Series B round was co-led by Salesforce Ventures and Spark Capital to support product development for tendering teams.
AutogenAI is a London-based enterprise artificial intelligence company that develops specialised writing and proposal tools for corporate bidding teams. Its platform helps organisations secure contracts more efficiently by automating elements of the tender process.
AutogenAI has secured £31.4m in Series B funding just four months after its previous raise, bringing its total capital to $65.3m. The round was co-led by Salesforce Ventures and Spark Capital, with additional participation from Blossom Capital. The fresh capital will be directed towards further developing the company's bid-writing product suite and expanding its technological capabilities.
Operating across three continents, the firm provides generative artificial intelligence tools designed to streamline the procurement and tendering process for Fortune 500 corporations, government agencies, and non-profits. The company reports that its software delivers significant cost savings and improved win rates for clients managing sensitive proposals.
From the founder
"Companies know that they need to embrace AI to reduce costs and drive expansion. AutogenAI has invested in thousands of hours of research to develop the very best competitive writing tool in the world. We are trailblazers in the field of AI knowledge theory,"
Sean Williams
founder and CEO at AutogenAI
Investor perspective
"The investment in AutogenAI by Salesforce Ventures highlights our conviction that AutogenAI’s software is a game-changer for enterprises that secure business via tendering and drafting proposals,"
Nowi Kallen
Managing Director, Salesforce Ventures
Use of funds
- 01Continue product development
